1. No category

 / %() /&# "' %%
! "#$# ./ +,- + " *) !
EB136/48 Rev.1
01 2 , 3!4 "
- " - 5, ,1! 3!4 -
5, ,1! 3!4 "#$# 61
%( /"9: %(* 78
! "#$ % & # ) # *( + ,- * .( ./$ 0 * ( "1 " # . # 23 0 "4 5 5
,23 1 :( , % # 67 (8 +9% 7* .@A ; /:= ,- >:? 7*
;
: # >$ 21 ,- 0 +9C $
:,2 "( IAH-7921 :GH ( #8 F F ,-
($)
3,4-dichloro-N-{[1-(dimethylamino) cyclohexyl]methyl}benzamide
:GJ ( #8 F F ,- ())
oxolan-2-one :,2 "( Igamma-butyrolactone(GBL)
•
(1,4-BD $ I1,4-BDO $ Ibutane-1,4-diol)1,4-butanediol
•
7* L:8 ; % & 1 " "1 7 *( #-$ 2 K .?: , % 1 6= * !M L .(5N #) IGG "# I ! 1 1 (( / EB136/48 Rev.1
:,2 "( I25B-NBOMe(2C-B-NBOMe)
•
2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
:,2 "( I25C-NBOMe(2C-C-NBOMe)
•
2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
:,2 "( I25I-NBOMe(2C-I-NBOMe)
•
2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
:GJ ( #8 ,6 F ,- (O)
:,2 "( IN-benzylpiperazine(BZP)
•
1-benzyl-1,4-diazacyclohexane
:,2 "( IJWH-018
•
naphthalen-1-yl-(1-pentyl-1H-indol-3-yl)methanone
:,2 "( IAM-2201
•
[1-(5-fluoropentyl)-1H-indol-3-yl](-naphthalen-1-yl)methanone
:,2 "( I3,4-methylenedioxypyrovalerone(MDPV)
•
(R,S)-1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one
:,2 "( IMethylone(beta-keto-MDMA)
•
(R,S)-1-(1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-one
:,2 "( IMephedrone
•
(R,S)-2-methylamino-1-(4-methylphenyl)propan-1-one
"4 " * = ! N 0 N$ I
8 Q -
P
1 7* IGJ ( 1 6R #8 0 P 18 ) 0
$ % 8R / , 2 * . # 8 + 9C
.. 9
)(/ # 8
&
N $ L 1 S (M 0 >: ? 9$
U2- T? ; .0 / 0# ,- 8 )( $ C N , 5 V & ! # 8 +9% T? $ 1- "6 .M
.U# : !. 6<4= ! 3!4 ;>
:,2 "( I( F( W , "() tapentadol hydrochloride
3-[(1R,2R)-3-dimethylamino-1-ethyl-2-methylpropyl]phenol hydrochloride
2
•
A
/ EB136/48 Rev.1
:,2 "( IJWH-073
•
(1-butyl-1H-indol-3-yl)(naphthalen-1-yl)methanone
:,2 "( IUR-144
•
(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone
:,2 "( IAPINACA(AKB-48)
•
N-(adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide
:,2 "( IRCS-4
•
4-methoxyphenyl - (1-pentyl-1H-indol-3-yl) methanone
:,2 "( IJWH-250
•
2 - (2-methoxyphenyl) -1- (1-pentylindol-3-yl) ethanone
:,2 "( I4-methylethcathinone(4-MEC)
•
(R,S)-2-ethylamino-1-(4-methylphenyl)propan-1-one
:,2 "( I4-fluoromethcathinone(flephedrone; 4-FMC)
•
(R,S)-1-(4-fluorophenyl)-2-methylaminopropan-1-one
:,2 "( Ialpha-methyltryptamine(AMT)
•
2-(1H-indol-3-yl)-1-methylethylamine with (R) and (S) stereoisomers
:,2 "( Imethoxetamine
•
2-(3-methoxyphenyl)-2-ethylaminocyclohexanone
:,2 "( Imethiopropamine(MPA)
•
1-(thiophen-2-yl)-2-(methylamino)propane
:,2 "( I( F( W , "() ketamine
.(±)-2-(2-chlorophenyl)-2-methylaminocyclohexanone
•
#8 ) 0 " 4 " N$ I(ketamine) Q -
H
9$ # . # +9C 1 7* IGJ ( 1 6R
,- ( I ,N F( ?7 #$ IL1 S(M 0 >:? U11 L: 7 Y3 & ! ILN F( ,- X +9$ ,- F N( 98
" ! F ! S U )$ L: Q1 & N$ .U( 3(
0# UN L: N $ .
0# C Q - 0
+9% " $ IT: & .U I, & 0# / Z 7 #$ 1- T: 5 .9 # ,- # .N # 0 >:? +9% ,- ! $ 3 I*
:, N ! [GJ ( 1 6R #8 0 018 .(@ - /,6 * A ,- +MN ") https://www.unodc.org/pdf/convention_1971_en.pdf
3
/ EB136/48 Rev.1
3AAA!4 AAA AAA;> 7@!AAA B AAA$ AAA<4 &AAA #CAAA AAA AAA! @AAA AAAD
J
%: B $ 6<4= ! ! "#$# :,2 "( I( F( W , "() lisdexamfetamine
•
(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide,(2S)-2,6-diaminoN-[(1S)-1-methyl-2-phenylethyl]hexanamide dimethanesulfonate
:‫ االسم الكيميائي‬،(‫ )اسم دولي غير مسجل الملكية‬tramadol
•
(±)-trans-2-(dimethylaminomethyl)-1-(3-methoxyphenyl)cyclohexanol
E4> ,<
0* % , 0 " ) ! #
\
,- 31 67 (8 0 S( ]3( @ ( /F ,
( 8 ] *( & 9$ 0 * >: ? F $ 5 # .
6M6 5 ( + 67 (8 0# % 5 XM 3 *R 5# .8 #^ ) I ?N 3 ( I3 X I16 F* I&#N 5($ ]?$ ,- 0* F2 "3( $
0# C 1 09 2 6_ "(( .
,- 5
. ($ X "X ,-" 0# "( "1 S( ,- I3 :; 5= !! F-
Q N I3 6M6 ;( 3 ,- $ , LN
G
0 N LN , /$ . 3 0#
LN , /$ ,- IGJ ( 1 6R #8 ,6 F ,- .#8 >:? F F ,- 8 N
(hydrochloride tapentadol) ? F F6 &N &( "(/ , 9/$
@
S(M ( F( W , "() (ketamine) I( F( W F , "()
. # 3 L$ +9% " $ .L1
F 8 9 , - F " 1 , - ] F ] / . 3- " a " 3 6 : I X "_ $ F 8 "= $ , !
, N $ IU# $ :? ^ "( "1 ^ - W & . 3N
]3") L1 S( ^ "$ :% ,$ S( ? :@!AA B AA1 .(" ) L1 S( % "$ :% ? Q( S(
F . F% $ F ,- O^ 7* # : ]3 a/ S( :AA B AA1 F $ F ,- 0 OC , 7 " b $ "$ ,. :% Z")
.("0 T Q - F
4
/ EB136/48 Rev.1
,- ( ILN )N L* )N ,- 5( QN F(
/
0X U ,89 & 1 N% 3(- .c N X +9$ ,- F N( 98
& 2 $ " $ 8 " )( 0 X. F( ( a
U 11 L: 7 Y? $ .8 0 ( ( F2 I
,- .& 2M
.a 0 F 1 $ G H! 5= !! #I
7* ^ 0 "4 " % 8* 0: P
. ) a$ # : 67 (8
F ( I& R 3 ] " , 67 (8 0 +8 & ! . ) 31 $ 59 67 (8 0 2M d # 3 - , : S( 9 $ T: 7* .16 ]
(8 5 3$ 33 ! *R ( L(
I ?N 3 3# 3( ?- a F6 I
,- 67
) T: ,- Ia #^ 5 3 *R >:? L(
.
^ , X , 0 "
I9 ( C ] ]( .
6M6 5( + 9 " # A
X ! ,- &9 G 9 , LN# b( a(
/ .
# 9( a/
?N 3 3# 3( - a "1 F$ 67 (8 T: ,- Ia$ 3 0 T >:? 59( .$ I , X , 0 " ) ($ X .
6M6 5( + ,- a/( , 9( 3 *(( IF I
^
ILN/1 X (( " :8 % 0 F ,- &9$ N* F H
0(% 5 # 9 - a ( X % ]3 , (( L$
- 7* 0 " 0 #8 5 * I3 3 ( 3(
.
7* GHJ+ K O 1 ( ( I@ /$ ,- J
! F L1 " "1 "6 I N * 8N XX
! T* .8N ,- 3( % ( F$ ILN/1 , I&$ & ,- > L: I$ ,- - % e ,- . $ , - - % ( F $ F I 98 U (($ L: - F$ ! >:8 T* , e T3- IT: &M9-
Ensuring balance in national policies on
! ! *% X :, N controlled substances
, - +M N " ) http://www.who.int/medicines/areas/quality_safety/guide_nocp_sanend/en/index.html
.(@ - /,6 * \
5
/ EB136/48 Rev.1
% ( ]3( I , 0 " ) , N(
.( ( # 9
J- &D K! - B ! 1# :; G ,9 J- G "! '0 3!4 " ! "# 61
L D<! %( !D /&# "0 *) 78
;
N $ 6 6 7 K $ N & 1 $ \
, F " # . N ( F 9- & 1- " (/ :W4 N/
,- + $ a 6 # 7* $ >:? F1
.
(^ 9 3($
N 1 3 7 * ( I *ٕ & 9$ 1 : ? L G
# 59 I5( 0. + $ ,- 6 # N( (
.F( ,- 6
Q U & ! 6 9 1 F ,- ! U$ L: F &9$ *# @
.3 : ) QN )6 1M N # I* F
1 I :W , - N 6 ,2: . ( 2? Y# ] ( ]8 N 0% *# >:? 8(( I 0 1 8(( I9# 6 >:3 (^ S F$ 2M N
.:W4 ,- N >:3 7 "( 7* N( % 3
a ( 8 -% ( ! * # 8 -% ( X :W ! * [ 7 1 3% ( , :
P.6 7*
Evaluation of certain veterinary drug residues in food (Seventy-eighth report of the Joint FAO/WHO
@ IG\\ "# I ! 1 1 (( .Expert Committee on Food Additives)
.(5N #)
2:. -9 (( .Toxicological evaluation of certain veterinary drug residues in food :, N ! ! 2:. -9 (( X .@ IHG "# I!
/, 6 * \ , - +M N " ) http://www.who.int/foodsafety/publications/monographs/en/
.(@ -
* .Residue evaluation of certain veterinary drugs .X :W4 0 " ! P
I@ I
( 6 + I 2:. - 9 ! X :W !
.@ IX :W ! IA -^ (
6
/ EB136/48 Rev.1
J # D< AAG AA,9 AAJ- AAG "AA! 'AA0 3AA!4 AA " !AA MAA 6AA1
L D<! :;
%( /"9: %*N 78
;
Ia$ 2:W -9 ( 8 1 I2:W -9 ( 7 &1 $ P
.3 F 7 "1 ^ &1- &3 &M \ "1 F " 1 7 1 3 ( 7 * ( I *ٕ 1 S .59 :W$ ,- "(/ , 2:. -9 Z I3
1 >: ? I 2:. - 9 ,2: . ( 2? Y# ] ( A
" ( 7 * N N ( % 3 % F $ 0 1
F$ 2M N ]8 N 0% 2:. -9 >:3 7
.37* ٕ I9# 6 -9 >:3 (^ S
a ( 8 -% ( ! * ]( H
! * .! 2:. -9 (( ,- 7 1 3% ( , :
.31 2:. -9 ? X :W
:; 5= !! F-
:W ,- 2 S )# a ]~ % F ( J
I& S :? )# ^ I6 N ,- >:? ,- F6 , I
I M* a% . _ Q- % ( N , 1 QN e FM $ N ) :/ $ ) , ^ 7* 9 ,2:. ( 2? L$) ! X :W ! T* 2:. 8 .(8 32?
I:W ,- 2 N 1 * 9 F 5 U \
2 ( 5 "! "1 ] , ((R F# a( T? ;
F 1 :? X $ ? - : .,#^ ,N : .(5N #) GG@ "# I ! 1 1 (( :, N ! ! 2:. -9 (( X /, 6 * \ , - +M N " ) http://www.who.int/foodsafety/publications/monographs/en/
.(@ -
.
M +8 :? Q P
7
/ EB136/48 Rev.1
N 4 0 1 N 1 ) 9
# > 6$ U ?$ Z & - F / .0: 2:. 6 2:. -9
= Q- % F % ,( 1 U LN I:. 7 7* . >:? "1 7*
*^ ?W :W 7 59 ,- ,2:. ( 2? "( G
) "1 9 , % 59 ;( % >:? ( . F$ 7 , 2:. 5( 0 $ T: 9 .* .:W 0 ,- ( 8 T3( 0 * 9 F ) & 9$ ,- 31 , 0* :R P@
.^ # :W 7 #^ $ N G H! 5= !! #I
6M6 1 1 .& ( &N* :W ,- 0 2 "1  / P
-9 ! X :W ! * I 2:. 6 - 9 7 * 1/ Z IT : : 8 " @P@ 0 8 , - 2:.
6 "1 7* = + 1
/ I[@P /
X ,- _ @ /
X ,- ?$
,- 6M6 1 1 .@P - /,6 * ,- :W ,- 0 N , - _ 1 1 @ /
X , - ? $ 1/ # I@A@ 0 8
.@A "
:W ! T * 2:. 8 e , - T * , ? ! P
01 & ! .,2:. ( 2? ,- ,(2 >X3 F6 L: I ! X
;( 7 2:. -9 ! X :W ! *
" 1 , 3- I :W , - 6 2:. - 9 7 * .,2:. ( 2? F % ( ? . "1 #^ ) ! ,6 ) & 9$ 1 "(/ PP
.:W 7 1 F2( 7* 9 F % 0*
AAG! AA AA :AA; AAG AA ! AA AA, M!AA 6AA1 AA
O! %( ! /+- "' * 7 (( € " ! ! ( 3 ( P
! #8 @ G ) .€ "! & &(($ - % ]3 1
.(5N #) IG\G "# I ! 1 1 (( 8
/ EB136/48 Rev.1
.€ "! 3% ( $ ,. , O3 1 >:? / I€ - 7* N^ .€ - (( 7* R( N 0 N % >:? S
V /
"! F ,- "1 X ^ ? . 91 F 5( + X PA
! #8 ,- ] N R ( 0 FM b9 ( I€
?W 0 € N *# 3 , 59 9 .€ - 7* N^
S 8 [Q 2 ) ( 0 1 : 2 ( [
" € [ 3 1 . : ( * W 2# [
^ )( U# O! ;
: N* F# U QN :ٕ € L :% & € e / PH
IT: FN$ 0- : Q( ,- e N ()) [( F1 0- : Q( ,- e /N ($)
[0 "( (O) [0 ,- U( " , "# $ ,- X Q( .a € 1 N F#$ # LN U$ Q(
‚ ()
, IS , - 3 ( N I3 ( a Z 0 € " 1 , . PJ
I >:3 "1 % "X .e "( ,-.
/ 5X I"( N IUٕ T3(
028 3$ Q( ,- N 1( 6 :% % ? $ ! 3 ,.
- 6$ I 2 U ( L: " 9 K 1" " 38 " 1 , . . % 8 U ٕ I & N F#$ 3$ "X , "( (
.2N ) " 3
:; 5= !! F-
* I- W ( I0 € "( 1 (2 Q1 Z 9 P\
I& N F #$ e F , 7 * 2N I€ " ( F $ P."OX "( :" TM3(
:, N ! X .(@ - /,6 * \ ,- +MN ") http://www.who.int/fctc/text_download/en/
I€ - 7* N^ ! #8 ,- ] N R X :, N I 18 IFCTC/COP5(10) 1 I())P 018 IFCTC/COP5(6) 1 !
.(@ - /,6 * \ ,- +MN ") http://www.who.int/fctc/cop/en/
_ - IT: 5 . 7* X Q1 & 6 € F*$ * X "( / P
TM3 ( % bN * I 1 : ? S W .OX " (M Q ( ] 7 * = Q - ;($ :? L$ "( 5 I0 € 2( TM3( $ I
" € 2(
., W $ ,
9
/ EB136/48 Rev.1
G H! 5= !! #I
5 a/ $ IQ( F* X ,- 5 e3 "( $ L9 PG
.3 X 0 € Z XM
"4 , O!
;
.
" € 3N , L F$ &9 6$ (( "( "X @
$ I8 ($ " € / I(
/ € L$) a 1) .F#$ 3- 3 # ? Q8 , I]9$ 3 , : 1 Ie  -^ 9 F6 IV 0‚ ( - (( XX
: 1 I3 ! I,3 ;4 a 1 ( ( I>! $ >:? Q( 1 S- I )29 0X I2M 8 , .3( N 9 7* " , :ٕ
:; 5= !! F-
3( T: ,- I
" € " 64 "? X M% ) ,- >:? "( % U Q( 0X I "( IOX "( I
1? )
.1. G H! 5= !! #I
I3 2 ? " € "( -9% % T? "3- % F ? - IT: &M9- . ] "( N )#
# % 8 M :8 9/ , R ٕ >:3 Q(
. >:? F F$ , F F: "X .0 "#$ ,- OM
@: P! : ! ;
1" ( IQ + N 2( ,- ( QN P
($ ,- Q2 )( 0 1 1 1 # ."Q2 )( 0
N( FX I, 0 1-$ )
>:3 F* QN ,- ,6 59 F6 .e3 :? 5 $ F 98
2 ] F $ I0 ,- K8 ) IT: Q1 F$ [2(
]# % "X .N 1 "X ( ,. M- T: 5 .€ ,- S8 Z 6% :% U - I >:? U11 L: 6 a
) , . . >: ? " ( , 2 ( N ^ - Q 2 )( 1 S8 7* , :% e , ( . ( a 1
.2( ,- Q2
10
/ EB136/48 Rev.1
:; 5= !! F-
,- )( Q , (2 N 9 Q2 /
&98 Q2 )( 0 1 1 QN , QN 3* # .- 2( 6 ,- Q- L$ 6 " .
1 Q2 ,- &1 „P@
"X e2 >:? S .a 2( Q2 )( 0 1 "( .€ (
,
2
G H! 5= !! #I
N ( ,- . 6 ( 7* Z X % "X A
- Q 2 , - F S 8 " 1 IQ 2 ) ( 0 1 : 2 (
.Q2 2# ! O! : &D 0 J ;
* W 2# € "! ! ( H
% ? F ) 2 ( , - 0 2 : ( % 9 .2( 6 € PG 21 >:? "9 I(0 J@@@
.8 ( : 2( ,- 0 X a 8 "( ,- 0 )(
.08 "1 1 a( ;# $ % ( :; 5= !! F-
"! U % ]N 3 ,- ( * W 21 LR( J
7* N^ ! #8 @ G U K L: I6
.0 ] - 5 0 21 >:? "1 0% ,. .€ -
G H! 5= !! #I
3 , 21 )( 5 # 3! 6 a/ $ ,. \
F$ 1 )( & * .! € *
Q1 FX .N [a] X & € ,- 0 X (/$
)( Q - $ . ^ # I3 0N 9 )(
" ;1 0 )($ N ,- * N% ,.- I 59 " ,
X (**) Z8 ,- € ,- K .
" € ,- [a] X & € ,- 0
" PK 3Q
.1 & N^ % ;
=
=
11
=
G